Agoracom Blog Home

Archive for the ‘Enertopia Corp.’ Category

CannabisFN Weekly: Stocks Tread Water amid Regulatory Gains

Posted by AGORACOM-JC at 2:06 PM on Tuesday, June 17th, 2014

Whitefish, MT / June 17, 2014 / The Marijuana Index(tm) traded roughly even last week, although the sector remains well below its highs achieved earlier this year.

Top gainers included Fusion Pharm Inc. (OTC: FSPM), which rose more than 70% last week driven by technical trading, and Novus Acquisition & Development Corp. (OTC: NDEV), which rose over 13% last week after making some executive appointments. Top losers included Extreme Biodiesel Inc. (OTC: XTRM) and IMD Companies Inc. (OTC: ICBU), which both fell more than 10% last week.

Cannabis regulatory initiatives also continued to pick up steam last week. In the U.S., Colorado announced the largest grant yet to be dedicated to medical marijuana research. Internationally, Mexico’s president indicated that the country may follow the U.S.’s lead when it comes to legalizing cannabis. Change may be happening slowly, but it appears to be headed towards liberalization over the long run.

What’s New?

Capitalize on Canada’s MMPR Rollout with Enertopia – CannabisFN takes a closer look at Enertopia Corp. (OTC: ENRT) and how the company is well positioned to take advantage of Canada’s new MMPR program.

Colorado Embarks on State-Funded MMJ Research – Colorado’s Department of Health will dole out about $9 million in grants over the next five years to study the effects of medical marijuana.

Cannabis Therapy Targets Low-Hanging Fruit – CannabisFN takes a look at Cannabis Therapy (OTC: CTCO) and its plans to leverage its seasoned management to take advantage of opportunities in the cannabis industry.

Mexico May Follow U.S. Lead in Legalization – Mexico’s President Enrique Pena Nieto recently indicated that the U.S. and Mexico couldn’t pursue diverging policies on marijuana legalization.

Intelligent Highway to Beat Q2 Revenue Forecast – Intelligent Highway Solutions Inc. (OTC: IHSI) expects to report a minimum of $450,000 in revenue for the second quarter of 2014, exceeding expectations.

Exclusive Interview Series

In a recent episode of CannabisFN’s Executive Interview Series, Mike Elliott sits down to talk with Enertopia Corp. CEO Robert McAllister about the company’s mission, plans to expand, and upcoming catalysts for shareholders.

Click Here: Watch the Full Interview

In a recent episode of CannabisFN’s Executive Interview Series, Mike Elliott speaks with Cannabis Therapy CEO Soren Moglesvang about the company’s upcoming plans to capitalize on the cannabis industry and some near-term catalysts.

Click Here: Watch the Full Interview

What to Watch This Week

The cannabis sector traded roughly even last week, with some gainers and losers offsetting each other for the most part. Bellwethers like GW Pharmaceuticals plc (NASDAQ: GWPH) rose nearly 8%, however, signaling that institutional investor interest remains high for companies able to capitalize on it. This week, traders should watch for more progress on the regulatory front to drive price action.

Upcoming Events

WeedStock Conference – June 29 to July 1, 2014 – The 1st Annual Cannabis Investor Conference in Denver, Colorado will feature networking events, industry speakers, expert panels, and more.

About CannabisFN

CannabisFN.com is a dedicated financial network covering new, emerging and established companies operating in the burgeoning multi-billion dollar medical marijuana (“MMJ”) and cannabis industries. CannabisFN’s coverage is syndicated on the leading industry specific and mainstream financial websites and social media. To learn more and request a media kit, visit http://www.cannabisfn.com/market-defining-companies-program/.

To subscribe to the CannabisFN newsletter or read additional coverage on cannabis laws and investments, visit http://www.cannabisfn.com.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

SOURCE: Emerging Growth LLC

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

US House of Representatives Votes to Stop Medical Marijuana Raids

Posted by AGORACOM-JC at 11:23 AM on Monday, June 2nd, 2014
Added by Scott Gaudinier on May 31, 2014.
Saved under Congress, Marijuana, Scott Gaudinier, U.S.
Tags: marijuana

marijuana

Medical marijuana, experiencing a huge spark with a recent outcry of public support across the United States, has now spread to members of Congress, as the U.S. House of Representatives votes to stop federal raids on those who use medical marijuana. Last Thursday evening the House passed an amendment that would prevent the Drug Enforcement Administration (DEA) from pursuing individuals and patients in states where medical use of the drug is legal.

Coming as a pleasant surprise to many citizens across the U.S., the House’s decision reached across party lines, with both Democrats and Republicans showing their support of the amendment with their votes. In a 219 to 189 decision the amendment, led by California Democratic Representative Sam Farr and California Republican Dana Rohrabacher, is the first amendment of its kind to succeed in the House of Representatives.

While the amendment was able to pass mainly due to vast support from Democratic members of the House, there was an observable majority of Republican votes cast in support of the said measure. For this to have happened, the amendment had already been previously backed by a group of co-sponsors from the two opposing parties.

The issue faced in the decision to stop medical marijuana raids was the fact that there was a “routine spending bill” which had been already in place. This allowed for federal tax dollars to be awarded to various government agencies, especially the Justice Department. In turn, the Justice Department has continued its raids of medical marijuana facilities in states across the country where medicinal sales are allowed and adhere to legal terms. However, the new amendment recently passed by the House hopes to prevent federal agencies from continuing these raids henceforth.

Director of Federal Policies at the Marijuana Policy Project Dan Riffle stated that Congress and the overall federal government have begun their shift toward “a more sensible policy” regarding pot, facing strong public pressure. He also made the statement that this vote is historically important after years of the government-initiated “war on drugs” during Ronald Reagan’s years in the White House.

While some critics have made their case that the amendment would only increase the misuse of an “addictive drug” and prevent the DEA from spotting illegal street dealers, House Republican Andy Harris stated in response how other drugs that are addictive have not been advertised as having positive medical benefits.

Unlike marijuana, which many health experts agree has improved patients’ general health, legal substances like nicotine and tobacco cause cancer and have not showed any positive medicinal benefits in any instance. As Harris said, “Nobody writes a prescription and says ‘Smoke a couple of cigarettes and cure your epilepsy.’”

As the U.S. House of Representatives votes to stop medical marijuana raids in the future through the passing of this new amendment, it faces other obstacles as it still needs approval from both the Senate and President Barack Obama. Yet many people across the country, including advocates, patients, doctors, average citizens, and an increasing number of politicians, remain steadfast in their hopes of a nearing reality of both the ultimate decriminalization and legalization of marijuana in the U.S.

By Scott Gaudinier

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Enertopia and Lexaria Update LOI with Signed Definitive Joint Venture Agreement

Posted by AGORACOM-JC at 5:00 AM on Thursday, May 29th, 2014

Vancouver, BC—Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce it has signed the definitive Joint Venture agreement as required in the Letter of Intent that was announced with Lexaria Corp on April 10, 2014.

The Definitive Joint Venture agreement was contemplated at the time of signing the initial April 10, 2014 agreement, and governs the procedures and practices by which the marijuana production facility in the Greater Toronto Area will be operated. As previously reported, Enertopia is paying 45% of costs in order to earn a 51% interest in the facility. The municipal approval process continues to proceed for this facility, located in the Greater Toronto Area

The Company also announces that 200,000 warrants have been exercised raising $20,000 in net proceeds.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Clark Kent at 1.647.519.2646

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation of clean energy projects, oil & gas projects, , competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements.  Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates.  The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.  There is no assurance that Lexaria Corp will conclude any Definitive Agreements. Similarly, there can be no assurance that the Company will be successful in attracting key people.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Toronto’s First Financial Investment Conference focused on Medical Marijuana, Industrial Hemp and Alternative Medicine Industries – June 26, 2014

Posted by AGORACOM-JC at 12:35 PM on Friday, May 23rd, 2014

YOU ARE INVITED TO ATTEND

Toronto GreenRush Financial Conference

WHEN June 26, 2014 7:30 a.m. – 6:00 p.m.
WHERE Metro Toronto Convention Centre, Level 100 Constitution Hall
TICKETS Register Online

The conference will feature insightful speakers from a diverse cross section within the above mentioned sectors including government, public and private companies, fund managers, bankers, brokers, investors, lawyers, accountants, analysts, and media representing all aspects of these industries we represent.

VISION: To be the Premier Purveyor of Investment Conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries.

MISSION: To provide a platform/hub to facilitate investment, education and business to business opportunities across the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

GreenRush Financial Conferences is 100% owned by Next Gen Metals Inc. (Next Gen, CSE:N)

After an extremely successful Vancouver conference, May 7, 2014, GreenRush Financial Conferences will be in Toronto on June 26, 2014.

FUTURE CONFERENCES:
CANADA, UNITED STATES AND EUROPE (TO BE ANNOUNCED)

Interested parties or companies wishing to attend the conference can register online by visiting www.greenrushfinancialconferences.com by phone 604.685.1870 Toll Free 1.800.667.1870
For further information on GreenRush Financial Conferences and to book a trade booth, please contact the following people listed below:
Taylor Duncan-Barr [email protected] 604 648.1405
Ray Rich [email protected] 604 648.1401
Ray Lagace [email protected] 604.648.1413

Recent Articles – Interviewskkjksd

About Next Gen Metals Inc., a diversified public company focused on providing financial solutions for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries.(CSE: N, OTC Pink: NXTTF, FSE: M5BN)
  • VISION: To be a Leading provider of venture capital, management expertise, education and a facilitator for this explosive new industry
  • MISSION: To Provide Financial Solutions for the Medical Marijuana, Industrial Hemp and Alternative Medicine Industries. Recent regulatory and legal changes in North America have aided Next Gen in accomplishing its mission in these emerging multi-billion dollar industries
  • NEXT GEN’S BUSINESS MODEL: Generates new industry business proposals and plans on a continuous basis. To that end, Management is currently negotiating with a number of companies who are interested in entering into contractual arrangement to co-venture, co-finance, and option-joint venture on one or more of Next Gen’s large inventory of business opportunities and existing 100% owned companies and projects in these multi-billion dollar industry.

GreenRush Analytical Laboratories (GAL)
A wholly owned Subsidiary of Next Gen

  • VISION: To become a leading Laboratory company focused on servicing the legalized cannabis industry in North America.
  • MISSION: To provide analytical testing for the Legal Cannabis Industry in North America by delivering customized solutions and accurate analytical results to our clients.

Recently proposed Canadian Medical Marijuana and Industrial Hemp laws and regulations are anticipated to set additional standards for licensed producers that require more detailed Quality control and Quality assurances from Licensed Producers. GAL is organizing a team of scientists and laboratory technicians to staff our first laboratory. Simultaneously GAL’s management continues to meet with targeted under-funded Analytical Laboratory opportunities for possible mergers and acquisitions.

Management is currently in the process of assessing and selecting initial locations and jurisdictions to establish the laboratories. Management’s objective is to initiate analytical laboratories in areas with the greatest concentration of Licensed Producers in both the legal Medical Marijuana and Industrial Hemp industries.


Next Gen is evaluating multiple new business plans and industry related proposals on an ongoing basis. Management continues to receive and review numerous proposals including: alternative medicine, health, food, agri-business, legal grow-ops, science and technology, client generation, education, public awareness, specialty clinics and ancillary business opportunities. The directors of Next Gen have given management the directive to identify core business opportunities and then to invest in a basket of companies within these emerging sectors.

Toddler’s seizures stopped after consuming cannabis oil, parents say

Posted by AGORACOM-JC at 10:50 AM on Thursday, May 22nd, 2014

JUSTIN GIOVANNETTI

VANCOUVER — The Globe and Mail

Last updated Tuesday, May. 20 2014, 8:05 PM EDT

Two-year-old Kyla Williams hasn‘t learned to walk or talk, her development has stopped as she suffered as many as 200 seizures daily and no medication helped. Now the girl’s family say she hasn’t had a seizure in a week, ever since they began giving her cannabis oil extracted from hemp. (handout from family)

Two-year-old Kyla Williams hasn’t learned to walk or talk, her development has stopped as she suffered as many as 200 seizures daily and no medication helped. Now the girl’s family says she hasn’t had a seizure in a week, ever since they began giving her cannabis oil extracted from hemp.

The oil being used by the toddler has high amounts of cannabidiol, known as CBD, the main ingredient in medical marijuana, and almost no psychoactive ingredients. Its use is in a legal “grey area,” according to proponents.

Only dried marijuana is currently regulated by Health Canada, the sale of resin and oil by growers is forbidden. The hemp that the cannabis oil is being extracted from is supposed to be destroyed by farmers under federal regulations. However, few controls seem to govern the dispensary and parents providing the two-year-old with the oil.

Despite the lack of legal clarity, Kyla is continuing to use her unconventional medicine. On Sunday evening, she had been seizure-free for a week.

“Within 20 minutes of administering it the first time, she stopped her seizures completely. She had six seizures earlier as I said goodbye to her, it was so hard to watch,” said grandmother Elaine Nuessler.

On Saturday, the girl’s grandfather spoke publicly about the need for greater access to the medical marijuana-like substance. A former RCMP officer, Chris Nuessler told a crowd of 60 in Summerland, B.C. that his views on marijuana have changed significantly since his granddaughter began showing signs of uncontrollable epilepsy when she was six months old.

“We come from a background where we’ve never dealt with marijuana before in our lives,” said Ms. Nuessler. “We’ve discovered that it’s a healing plant.”

For more than a year, Kyla was treated with a battery of prescription drugs, none worked, many made her condition worse. Due to the epilepsy, the girl also suffers from serious visual impairments.

After being told by physicians that the girl’s life would be cut short by the seizures, the family contacted Jim Leslie at the Nation’s Best Weeds Society, a dispensary in Vancouver’s east end. Aided by anecdotal evidence that cannabis with high levels of CBD was being used successfully in the United States, Mr. Leslie set out to find something similar in Canada.

He soon came across an often discarded piece of hemp that is high in CBD. “We’ve got a winner here,” he remembers thinking when he saw the results of tests on the plant. “A small, small percentage of farmers are diverting the CBD-rich part of the plants to us,” said Mr. Leslie.

The Vancouver-based dispensary has a note from Kyla’s pediatric physician recommending cannabis. Under federal rules, the family should be providing the two-year-old with medical marijuana in it’s more traditional form.

In the past, Canadians have moved to the U.S. to gain access to the oil. In late 2013, the parents of 13-month-old Kaitlyn Pogson moved to Colorado to obtain the drug, hoping it would help with their daughter’s severe seizures.

With no medical trials showing that cannabis helps children with seizures, Arthur Schafer warned that the impact of the drug’s exposure on a child’s brain remains unknown.

“The rigorous scientific evidence isn’t there, but the anecdotal evidence seems quite promising. Would a reasonable and loving parent take the risk of giving their child medication that could cause serious harm? Not unless the situation is desperate and nothing else has worked,” said Mr. Schafer, the director of the Centre for Professional and Applied Ethics at the University of Manitoba.

“If the harm is there in front of you daily in seizures, the reasonable and loving parent might take the risk. I would.”

Follow Justin Giovannetti on Twitter: @justincgio

Source: http://m.theglobeandmail.com/news/british-columbia/toddlers-seizures-stopped-after-consuming-cannabis-oil-parents-say/article18769814/?service=mobile&cmpid=rss1&click=sf_globe

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Pot Firms Gain as CVS, Walgreen Competition a Pipe Dream

Posted by AGORACOM-JC at 2:13 PM on Tuesday, May 13th, 2014
By Shannon Pettypiece and Sonali Basak May 13, 2014 12:01 AM ET

Photographer: Kathryn Scott Osler/The Denver Post via Getty Images

Kayvan Khalatbari, has poured $500,000 into pot production and $150,000 into a store, started in the industry by delivering medical marijuana door to door. This year, he expects sales of almost $2 million, which may rise to $5 million once he can also begin selling the drug commercially under Colorado law.

Americans seeking medical marijuana for anything from pain to seizures must turn to a patchwork of small startups for help as U.S. laws keep traditional pharmacies out of a market that may exceed $6 billion by 2019.

While more than 21 states have legalized pot for medicinal use, the drug remains illegal under federal law and banks are hesitant to accept money from its sale. That’s keeping drugstore chains CVS Caremark Corp. (CVS), Walgreen Co. and Rite Aid Corp. (RAD), out of the market, leaving local entrepreneurs in control.

“We aren’t going to see a big guy enter this market within the next few years,” said David Yang, an analyst with research firm IBISWorld. “There are just too many regulations and too many elements that make this impossible for them.”

In one state alone, Colorado, more than 400 companies are licensed as medical marijuana centers, with government officials predicting sales there could soon reach $1 billion. For Colorado businessman Kayvan Khalatbari, a former electrical engineer who started his business with just $4,000, federal limitations on the drug are a major benefit.

Khalatbari, who has poured $500,000 into pot production and $150,000 into a store, started in the industry by delivering medical marijuana door to door. This year, he expects sales of almost $2 million, which may rise to $5 million once he can also begin selling the drug commercially under Colorado law, he said.

“We’re making money, we’re employing people, we’re being a beacon of light for this industry and showing it can be done professionally,” Khalatbari said in a telephone interview. “That to me is a success.”

Federal Law

Traditional pharmacies, meanwhile, face a hurdle that keeps them from competing with entrepreneurs like Khalatbari. Even though almost half of states and the District of Columbia accept the drug’s use for medical purposes, marijuana isn’t deemed legal by the federal government. The drug is classified as a Schedule I controlled substance, defined as having a high potential for abuse with no accepted medical use.

The Legalization of Marijuana

Schedule 1 drugs, which includes heroin, can’t by law be prescribed or dispensed. Pharmacies must register with the U.S. Drug Enforcement Agency to dispense controlled substances, making it illegal for them to sell medical marijuana.

Walgreen, Rite Aid and CVS said in separate statements they have no plans to sell medical marijuana. Doing so, according to CVS spokeswoman Carolyn Castel, would violate the company’s registration with the DEA.

Tax Revenue

That may change if the U.S. Congress sees taxes on the drug as a way to raise money, said Brad Barker, an analyst with Bloomberg Industries in New York.

“The second this is legalized they will start rolling out the marijuana cigarettes the next day,” Barker said. “I think the same thing can be said with everything else. Then you’ll have all the big boys jumping into this space.”

More pharmacies would sell medical marijuana if drug companies created cannabis products that can be approved by federal regulators, like drugs or tobacco products, said Mark Kleiman, a professor of public policy at the University of California at Los Angeles School of Public Affairs.

“It’s not drug stores that have to make these decisions, its pharmaceutical companies that have to decide if they want to make cannabis products,” Kleiman said in a telephone interview. Eventually, that could fuel a “big threat to the medical dispensary business model.”

Existing Products

Existing pharmaceutical cannabis products include Marinol, a prescription pill made with synthetic cannabinoid for uses including treating nausea associated by chemotherapy, sold by AbbVie Inc. (ABBV), and Sativex, a spray form of marijuana produced by GW Pharmaceuticals Plc (GWP), a U.K.-based medical marijuana research and development company. Sativex isn’t available in the U.S.

Shareholders are already investing in publicly traded marijuana companies like GW Pharmaceuticals and Advanced Cannabis Solutions Inc. (CANN), a company that leases growing facilities to licensed growers and dispensaries. Barker said he’s tracking 160 public marijuana companies.

American depositary receipts for GW Pharmaceuticals have increased more than sevenfold in the past 12 months to $69.77, raising the company’s market capitalization to $1.24 billion. Shares of Colorado Springs, Colorado-based Advanced Cannabis Solutions, with a market value of about $210 million, has risen more than ninefold to $15.75.

New Investors

Next Gen Metals Inc. (N), a mineral exploration company, is among the investors preparing to put private capital into marijuana startups.

“You can certainly believe the large industries, the large pharmaceutical companies, that they’re looking into it,” Jay Oness, Next Gen’s chief operating officer, said. “When the time is right, I’m positive they’ll want to be a part of it either through acquisitions or by themselves.”

Until legalization or more products are marketed by pharmaceutical companies, it will be an industry dominated by small dispensaries set up to serve about 1.4 million medical marijuana cardholders using the drug to treat their symptoms.

Three states allow medical marijuana companies to make a profit from the sale of pot. The remaining 18 states that approve of the use of medical marijuana require distribution only by nonprofit organizations and cooperatives, according to the Marijuana Policy Project.

To contact the reporters on this story: Shannon Pettypiece in New York at [email protected]; Sonali Basak in New York at [email protected]

To contact the editors responsible for this story: Reg Gale at [email protected] Andrew Pollack

Source: http://www.bloomberg.com/news/2014-05-13/pot-firms-gain-as-cvs-walgreen-competition-a-pipe-dream.html

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Industrial Hemp and Medical Marijuana Industry Gather for GreenRush Financial Conference in Vancouver

Posted by AGORACOM-JC at 10:58 AM on Monday, May 5th, 2014

Next Gen Subsidiary Announces First of Global Series of Industry, Finance and Investment Conferences

VANCOUVER,B.C., May 5, 2014 (GLOBE NEWSWIRE) — A hundred and fifty years ago, Harry Barr’s (President and CEO of Next Gen Metals) (CSE:N) (OTC Pink:NXTTF), ancestors began farming in the Ottawa Valley. As far back as pre WWII, the family farm was producing hemp, which in those days was used primarily for rope for the War Act.

At 23, a young Harry Barr graduated from the University of Guelph in Agribusiness and began a career that forged him into a global mining executive and financier. Barr notes that since 1985, every exploration company he has started is still in business today and managed from Vancouver.

Now, Barr’s company has seized the opportunity to incubate and mentor those legal marijuana and hemp companies that have the technical savvy, but require the business acumen that any new or expanding industry needs; be it fundraising, complex negotiation skills, capital markets expertise, public company administration or IPO’s.

Those tenets will take shape in a big way on May 7th, when Next Gen’s 100 percent-owned subsidiary, GreenRush Financial Conferences launches in Vancouver at the Convention Centre East and the Pan Pacific Hotel with the first of a series of global Medical Marijuana and Industrial Hemp conferences, bringing together stakeholders, investors, companies and the legal community. Simply put, these conferences intend to be the premier purveyor of investment education and finance for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

“I applaud Mr. Barr for being a pioneer and recognizing the lack of Marijuana expositions in Canada that focus on finance,” stated Mike Withrow, President and CEO of Abattis Bioceuticals Corp (OTC PINK:ATTBF). “We now have a forum to tell the world about our Grow Dry Extract Refine and Sciences model coined GDERS.”

“The Medical Marijuana business is slowly recapitalizing the junior mining industry in Canada,” stated Harry Barr, CEO of Next Gen. “But more than that, it is quickly bringing together the legal and industry forces necessary to give a complex, highly regulated market the visibility and transparency that investors require.”

Barr’s quote that the Medical Marijuana Industry is recapitalizing junior mining is a result of the fact that Canadian Securities Laws have allowed for thousands of Venture Capital companies to be formed. Given the mining downturn of the last three years, many of these entrepreneurs with proven fund raising and capital market abilities are now taking their shareholders into this new multibillion-dollar industry.

As well as discussing direct investment opportunities, the GreenRush Conferences will focus on the latest Medical Marijuana research, legal issues and give an overview of the industrial hemp market and the role of Alternative Medicines.

There is little chance that growth in this space will retreat anytime soon. The majority of support for the legalization exceeds 50% in Boomers and hits 65% for Millennials. From 1969 to 2013, legalization of marijuana supporters grew from 12% to 52%. Those wanting it to remain illegal dropped from 84% to 45% in the same period.

Barr was an early adopter who, using mining parlance, staked his claim in the Medical Marijuana space well before most others. Unlike some juniors, from Day One, his approach was not knee-jerk opportunism, but a well thought out business strategy utilizing decades of business acumen to add consistent shareholder value.

Management of Next Gen (as well as other entrepreneurs) is very good at raising capital. The Company intends to extend its brand to this industry and is actively seeking and reviewing new business plans. It intends to be a leader in the space and the go-to Company for legal marijuana and industrial hemp investments.

Barr is also the driving force of the International Metals Group (IMG), a brain bank of project acquisition, exploration and development professionals, including dedicated CEOs, geologists, engineers, corporate finance and investor relations experts, corporate managers, public company administrators, and regulatory and government affairs specialists.

To date, IMG companies (past and present) have completed over 300 option/joint venture agreements with major, mid-tier and junior companies and raised over $250,000,000 to advance their projects throughout 9 countries.

Barr could well be right in his assumptions, being a fixture on the mining scene for 29 years. As CEO, Chairman and Director of Pacific North West Capital Corp, he is also Chairman and CEO of El Nino Ventures, President of Next Gen Minerals (CSE:N) (OTC Pink: NXTTF) and Chairman of Southern Sun Minerals. Pacific North West Capital Corp is a controlling shareholder of Next Gen (22%), approximately 10% of El Nino Ventures and has a modest but important stake in Southern Sun Minerals.

Barr is not abandoning his mining roots and projects. In Ontario, Barr’s Pacific Northwest Capital made a grass roots discovery on its River Valley Platinum Group metal property, which is now a multi-million ounce deposit. The Group’s mining team is working hard to joint venture this advanced stage project with a company capable of financing this project to production.

As well, in Bathurst, New Brunswick, Mr. Barr’s El Nino Venture’s has two option agreements with Glencore Canada and Brazil’s second largest mining company Votorantim. Earlier this year El Nino won a five-year international arbitration on its D.R.C. copper discovery freeing up this project for continued development.

The GreenRush Financial Conference Exhibitor Space opens at 7:00 am; the opening talk is at 8:00am and concludes at 6:pm on May 7th at the Vancouver Convention Centre East and Ballrooms A/B/C/ in the Pan Pacific Hotel. The final hour hosts a discussion entitled; “The Great Debate: Legalization versus Prohibition,” followed by drinks and informal networking and discussion.

As well as an impressive lineup of speakers, there is an exhibitor hall with representatives from the Medical Marijuana community, investment dealers, financial professionals, media and the legal profession. Investors, media and other interested individuals can register through the conference site at www.greenrushfinancialconferences.com.

Of the more than two-dozen speakers are Bruce Linton from Tweed Marijuana (TSX-V:TWD), Harry Barr from Next Gen Metals, Chris Bunka from Lexaria Corp (OTCQB:LXRP), Craig Goodwin of Naturally Splendid (TSX-V:NSP), John Conroy of Conroy & Company and Daniel L. Kiselbach from Deloitte.

While the Medical Marijuana market represents a unique investment opportunity, it is important for investors to arm themselves with the facts in this complex, burgeoning market. Highly regulated, the companies that do the stringent due diligence necessary and develop the most growth-oriented alliances and partnerships will undoubtedly be the names that rise to the top as the space matures and garners increasing investor interest.                                                                                                                             

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the author’s only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.

CONTACT: 650 - 555 West 12th Avenue, City Square, West Tower
         Vancouver, B.C. V5Z 3X7 Canada
         Telephone: 604.685.1870 Facsimile: 604.685.8045
Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana 
Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Enertopia Announces Former Chief of Police as Security Consultant

Posted by AGORACOM-JC at 8:00 AM on Monday, May 5th, 2014

Vancouver, BC—Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce additional member to the Company and for the new Ontario marihuana production facility.

The former Chief of Police of the Hamilton Police Service has become Security Advisor to the Enertopia/Lexaria joint venture. Mr. Brian Mullan will provide advice to the Board of Directors and to management on the safe production, storage, and shipment of controlled substances; as well as provide and manage security protocols and procedures consistent with the needs of a medical marijuana facility and its staff.

Brian was a career police officer who retired as the Chief of Hamilton Police Service in December 2009 after having been a member for over 35 years.  He is the President of Bmullan and Associates.  Brian has received the Police Exemplary Service Medal and he has been appointed as a Member of the Order of Merit for Police.  Brian has a Bachelors Degree in Business Administration.  He is a graduate of the F.B.I. Academy in Quantico Virginia and the F.B.I’s prestigious National Executive Institute.  Brian has also attended the University of Toronto’s Rotman School of Business, Mohawk College and Bay Area Leadership Program, and he has been active in his community.

“I welcome Mr. Mullan to our joint venture team that we continue to assemble with the expertise and ability to operate our planned top tier production facility, that is focused on building one of the largest and most secure regulated marijuana production facilities in Canada” said Robert McAllister, President CEO of Enertopia

Mr. Mullan is eligible to receive up to 225,000 restricted common shares of stock, over time in his respective role as Security Consultant, depending on certain specified performance thresholds being reached.

 

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP in the United States with symbol ENRT. For additional information on this press release, please visit www.enertopia.com or call Clark Kent at 1.647.519.2646 or President Robert McAllister at 250.765.6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, evaluation of clean energy projects, Oil & Gas Projects, Medical Marihuana Projects  for participation and/or financing, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements.  Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates.  The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities.  There is no assurance that the Company will be successful in completing any anticipated financing and or its joint Venture partners will receive their Health Canada license under the new regulations or any will future sales will result or any consultant will have a material impact on the Company.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

 Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Canada’s First Medical Marijuana, Industrial Hemp and Alternative Medicine Investment Conference – May 7th in Vancouver

Posted by AGORACOM-JC at 11:43 AM on Friday, May 2nd, 2014

GreenRush Financial Conferences is a wholly owned subsidiary of Next Gen (PubCo, CSE: N, OTC Pink: NXTTF, FSE: M5BN). GreenRush’s vision is to be the premier purveyor of investment conferences for the Medical Marijuana, Industrial Hemp and Alternative Medicine industries.

The conference will feature insightful speakers, government, health and industry specialists, public and private companies, fund managers, bankers, brokers, analysts, and media who share a common interest in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors. GreenRush Conferences will be tailored to institutional, high net worth and retail investors with a focus on education and investment in the Medical Marijuana, Industrial Hemp and Alternative Medicine sectors.

Interview  Article   Article  Interview  Video Video

Speaker and Exhibitor Lineup – May 7th Vancouver Conference

VancouverGreenRush Financial Conference
May 7, 2014 7:00 a.m. – 5:00 p.m.
Vancouver Convention Centre East, Ballrooms A/B/C

 CLICK HERE TO REGISTER

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Enertopia Announces Assistant Operations Manager

Posted by AGORACOM-JC at 2:04 PM on Wednesday, April 30th, 2014

Vancouver, BC / April 30, 2014 / Enertopia Corporation (ENRT) on the OTCBB and (TOP) on the CSE (the “Company” or “Enertopia”) is pleased to announce additional members to the Company and for the new Ontario marihuana production facility.

Enertopia announces Mr. Chris Hornung as Assistant Operations Manager. Chris has been vice-president of Kenex Manufacturing Co. in Brampton, Ont., since 1999. During this time he has co-founded and grown several successful new divisions. As well, Mr Hornung is a partner in and is responsible for several different real estate holding companies in Vaughan and Brampton, Ont.

“I look forward to working with Mr. Hornung and our complete joint venture team that we continue to assemble for our planned world-class production facility, our team is focused on building one of the largest and most secure regulated marijuana production facilities in the world” said Robert McAllister, President CEO of Enertopia

Enertopia will be showcasing the company’s MMJ projects at the Las Vegas Money Show May 12th-15th at booth #316 and Enertopia’s President Robert McAllister will be presenting on Wednesday May 14th at 1:30PM to 2:00PM on the Canadian Federal Regulations and individual State Regulations in the MMJ sectors. On Wednesday May 14th at 3:00PM to 3:30PM President Robert McAllister will be presenting specifically on Enertopia’s MMJ projects across Canada.

The company has also received warrant exercises for 200,000 shares for $40,000 dollars net proceeds to the company.

Mr Hornung is eligible to receive up to 472,500 restricted common shares of stock, and of stock over time in his respective role as Assistant Operations Manager, depending on certain specified performance thresholds being reached.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Clark Kent at 1.647.519.2646 or Dale Paruk, President, Coal Harbor Communications Ltd. at 1.604.662.4505

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, evaluation of clean energy projects, Oil & Gas Projects, Medical Marihuana Projects for participation and/or financing, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that the Company will be successful in completing any anticipated financing and or its joint Venture partners will receive their Health Canada license under the new regulations or any will future sales will result or any consultant will have a material impact on the Company.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap Medical Marijuana Stocks Gateway
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks